[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-434938-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-434938-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","guidelines-on-primary-healthcare-for-type-2-diabetes-in-china-2025","Guidelines on primary healthcare for type 2 diabetes in China, 2025","","Diabetes prevalence in China has risen markedly in recent years, with an estimated 11.9% of Chinese adults affected in 2020, alongside major obstacles in prevention and glycaemic control, particularly in primary medical care. In 2025, national guidelines were issued by the Office for Primary Diabetes Care of the National Basic Public Health Service Program and the Chinese Diabetes Society to support comprehensive, continuous care for adults aged ≥18 years with type 2 diabetes, covering management requirements, processes, diagnosis, screening, evaluation, treatment, acute complications, TCM, referral, and patient education.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/guidelines-on-primary-healthcare-for-type-2-diabetes-in-china-2025/434938/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/guidelines-on-primary-healthcare-for-type-2-diabetes-in-china-2025/434938.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the 2025 guidelines for type 2 diabetes in China?","Question",{"text":63,"@type":64},"To guide primary healthcare providers in delivering comprehensive, continuous diabetes care, enabling prevention and control and standardising management approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Who are the management targets covered by the guidelines?",{"text":68,"@type":64},"Adults with type 2 diabetes mellitus aged 18 years and older.",{"name":70,"@type":61,"acceptedAnswer":71},"What key topics are included in the guidelines?",{"text":72,"@type":64},"Basic management requirements; health management process; diagnosis, screening, and evaluation; treatment; recognition and management of acute and chronic complications; traditional Chinese medicine approaches; referral; and health management and education.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},434938,1790829304,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Open access Review  \nGuidelines on primary healthcare for type 2 diabetes in China, 2025  \nWeiping Jia  ,1 Dalong Zhu  ,2 Lixin Guo  ,3 Liming Chen  ,4 Chun Cai  ,1 Jun Song  5  \nTo cite: Jia W, Zhu D, Guo L, et al. Guidelines on primary healthcare for type 2 diabetes in China, 2025. Fam Med Com Health 2025;13:e003765 . doi:10.1136/fmch-2025-003765  \nReceived 15 November 2025 Accepted 25 November 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, the Office for Primary Diabetes Care of the National Basic Public Health Service Program, Shanghai, China  \n2Department of Endocrinology, Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China 3Department of Endocrinology, Beijing Hospital, National Center for Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China  \n4Tianjin Medical University Chu Hisen-I Memorial Hospital, Tianjin, China  \n5Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China  \nCorrespondence to  \nDr Weiping Jia; [wpjia@sjtu.edu.cn](wpjia@sjtu.edu.cn)  \nABSTRACT  \nIn recent years, the prevalence of diabetes in China has increased significantly, and approximately 11.9% of Chinese adults had diabetes in 2020. Moreover, there are several rigorous challenges in diabetes prevention and glycaemic control, especially at the primary medical care level. In order to guide primary healthcare providers in providing comprehensive and continuous care to affected patients, the Office for Primary Diabetes Care of the National Basic Public Health Service Program and the Chinese Diabetes Society issued national guidelines for the prevention and control of diabetes at the primary care level in 2025. The management objects were adults with type 2 diabetes aged ≥18 years. The main contents include basic requirements for management, health management process, diagnosis, screening, evaluation, treatment, recognition and management of acute complications, traditional Chinese medicine, referral and health management and education.  \nINTRODUCTION  \nThe prevalence of diabetes in China has increased significantly in recent years, and approximately 11.9% of Chinese adults had diabetes in 2020.1 Moreover, onset is occurring in younger patients, and prevalence in rural areas is also increasing rapidly.1 Diabetes can damage the retina, kidney, nervous system and cardiovascular system and is the major cause of blindness, kidney failure, cardiovascular and cerebrovascular events and amputations, thus exerting a heavy burden on the Chinese health system. According to a recent China National Diabetic Chronic Complications Study, the estimated prevalencesof diabetic retinopathy (DR) and chronic kidney disease (CKD) among Chinese adults with diabetes are approximately 16.3% and 32.6%, respectively.2 3 However, diabetes can be prevented and controlled, and early detection and comprehensive management can help prevent complications and reduce the rates of disability and early death rates associated with diabetes.  \nIn order to guide primary healthcare providers in providing comprehensive and continuous diabetes healthcare, the Office  \nfor Primary Diabetes Care of the National Basic Public Health Service Program and the Chinese Diabetes Society have compiled guidelines based on the recent progress on diabetes prevention and management in primary healthcare in China. The management objects are adults with type 2 diabetes mellitus (T2DM) aged ≥ 18 years. The main contents include basic requirements for management, the health management process, diagnosis, screening, evaluation, treatment, recognition and management of acute and chronic complications, traditional C","cbCaifgrf6GOhp8D","https://ap.wps.com/l/cbCaifgrf6GOhp8D","pdf",1320105,14,"English","# Abstract\n# Introduction\n# Basic Requirements for Management","[{\"question\":\"What is the main purpose of the 2025 guidelines for type 2 diabetes in China?\",\"answer\":\"To guide primary healthcare providers in delivering comprehensive, continuous diabetes care, enabling prevention and control and standardising management approaches.\"},{\"question\":\"Who are the management targets covered by the guidelines?\",\"answer\":\"Adults with type 2 diabetes mellitus aged 18 years and older.\"},{\"question\":\"What key topics are included in the guidelines?\",\"answer\":\"Basic management requirements; health management process; diagnosis, screening, and evaluation; treatment; recognition and management of acute and chronic complications; traditional Chinese medicine approaches; referral; and health management and education.\"}]","Guidelines on primary healthcare for type 2 diabetes in China, 2025 | PDF",1790671192,35]